EGFR and colonic neoplasm: However, a better survival trend to signification can be observed in relation with the following clinicopathological characteristics: patients without any mutation (candidates to anti‐EGFR therapies), male patients, left‐side colon tumors, patients treated with antiangiogenics, and patients with preserved MMR protein expression.